Servier presents its 2018/19 financial results and R&D pipeline
All the news from Servier Group
Parkinson: Servier and Oncodesign reach ahead of schedule a key first milestone in their strategic partnership
Immuno-inflammatory diseases: Servier partners with University College of London
The Servier Arklow industrial site celebrates its 30th anniversary
Servier at ASH 2019
Mécénat Servier Charity Fund launches microDON for its employees in France
In early May, Servier launched a new worldwide awareness campaign called “Because I Say So”
Autoimmune Diseases: first option within global license agreement exercised for clinical development of OSE-127
Servier and Pfizer Announce Preliminary Results of the First-in-Human Trials of UCART19 Will Be Presented at the 59th American Society of Hematology (ASH) Annual Meeting